News
Plasma satellite propulsion startup Phase Four: We’re already booking commercial orders
8/13/2018[Story from the Space Intel Report cannot be cut and pasted.]
Millendo Therapeutics goes public with OvaScience reverse merger
8/13/2018Millendo Therapeutics, an Ann Arbor, MI-based biotech company developing drugs to treat endocrine diseases, is now a public company and has $30 million of new cash to continue work on its treatments for rare disorders. Millendo announced this morning that it plans to merge with OvaScience (Nasdaq: OVAS), which was...
Vesper MEMS in the WSJ: Tiny microphones are moving us toward a world where all gadgets can respond to a voice command
7/13/2018If every tree falling in every forest might soon be heard by an internet-connected microphone, what hope is there for our privacy? Already when you’re sitting in a room with an iPhone, an Apple Watch and a smart assistant like Amazon Echo or Google Home, you’re surrounded by a dozen...
Detroit becomes the first city in America to deploy independent self-driving vehicles in an urban core on public roads
6/27/2018DETROIT, June 26, 2018 — May Mobility, an Ann Arbor startup building self-driving vehicles, in partnership with Bedrock, a full-service real estate firm, today announced the first commercial deployment of independent autonomous vehicles on public streets in any urban core in America. The partnership will immediately embed self-driving shuttles into...
Forbes: May Mobility Is Deploying Self-Driving Vehicles Now, Starting In Detroit
6/27/2018The resurgent city of Detroit, which lost 64 percent of its population between 1950 and 2017, is experiencing something it hasn’t seen in decades: urban congestion. With little public transportation, virtually everyone in the Motor City drives to work, creating traffic and parking challenges, especially downtown. No one knows this...
Self-driving shuttle startup May Mobility partners with auto supplier Magna
6/14/2018Magna, one of the largest tier-one automotive industry suppliers in the world, has teamed up with Michigan-based startup May Mobility for the building and deployment of self-driving shuttles. The plan is to scale May Mobility’s self-driving shuttle fleet across the U.S. The initial fleet will debut for passengers on June...
Cellectar receives orphan drug designation for CLR 131 to treat rhabdomyosarcoma, a rare pediatric cancer
5/11/2018Cellectar Biosciences has announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to CLR 131 for the treatment of rhabdomyosarcoma, a rare pediatric cancer. CLR 131 is the company’s lead Phospholipid Drug Conjugate (PDC) product candidate, and exploits the tumor-targeting properties of the company’s proprietary phospholipid...
U-M startup Give and Take in Inc… “How to Build a Better Company With More Engaged Employees in Just 5 Minutes a Day”
5/7/2018Givitas can make asking for and getting help from other employees simple — which can make your business a lot more efficient and effective. Asking for help can make you feel insecure. Asking for help can make you feel vulnerable. Asking for help — especially inside internally competitive organizations —...
NanoBio closes $10M funding round, changes name to BlueWillow Biologics, and plans to take NanoVax nasal spray vaccine platform into clinical trials
5/7/2018Ann Arbor-based NanoBio Corp., considered by many as perhaps the most successful fundraiser in the history of state tech startups, has raised another funding round as it makes a pivot in search of a profitable market for its molecular technology. The pivot is drastic enough that it includes renaming itself...
Boston Scientific buys U-M startup Securus for $40M to add to heart imaging lineup
4/6/2018Medical device giant Boston Scientific has acquired Securus Medical Group, a startup with FDA-cleared technology that measures and images temperature in the body during heart rhythm procedures. Marlborough, MA-based Boston Scientific (NYSE: BSX) said Tuesday that it paid $40 million up front for the stake in Securus that it did...
TIME: U-M’s nasal flu vaccine, FluMist, is set to come back next year
3/21/2018After a two-year hiatus, the nasal flu vaccine is set to return to doctors’ offices next year. The Advisory Committee on Immunization Practices (ACIP) voted 12 to 2 on Wednesday to return the nasal spray to the CDC’s list of recommended vaccines for the 2018-2019 flu season. Pending final approval...
U-M startup ViewPoint Therapeutics raises $35 Million in Series B financing
3/16/2018ViewPoint Therapeutics, Inc., a privately-held biotechnology company pioneering the development of crystallin stabilizers to prevent and treat cataracts and presbyopia, today announced the closing of a $35 million Series B financing. The financing was led by The Rise Fund with participation from Novo Holdings A/S. Additional participants included ViewPoint’s existing...